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X-linked Adrenal Hypoplasia Congenita (X-linked AHC) is a rare disorder associated 
with acute adrenal insufficiency in the newborn age that typically cause vomiting, 
feeding difficulty, dehydration, and shock due to a salt-wasting episode. Hypoglycemia, 
frequently presenting with seizures, may be the first symptom. If untreated, adrenal 
insufficiency is lethal.  
Affected males, despite hormonal treatment, typically have delayed puberty (onset after 
age 14) caused by hypogonadotropic hypogonadism, and most of them are infertile at 
adult age. Carrier females may occasionally have symptoms of adrenal insufficiency or 
hypogonadotropic hypogonadism, possibly caused by skewed X-chromosome 
inactivation. 
X-linked AHC is caused by mutations in NR0B1 gene, a critical gene involved in the 
development of adrenals and hypothalamic-pituitary-gonadal axis. Since the 
identification of the NR0B1 gene, numerous mutations have been discovered including 
deletions, alterations of splice-sites, missense, nonsense and frameshift mutations.  
 
Here we present the molecular results obtained in three Portuguese families with 
NR0B1 mutations. Mutation analysis was performed by PCR followed by SSCP 
analysis and sequencing of DNA fragments showing abnormal patterns on a second 
PCR product, or by direct DNA cycle sequencing of PCR products. 
 
Molecular analysis of the NR0B1 gene in proband A revealed a nonsense mutation, 
c.1084A>T, p.Lys362*, in exon 1, not previously described. His mother and sister were 
asymptomatic carriers; in family B a nonsense mutation, c.243C>G; p.Tyr81*, also in 
exon 1, was identified in two affected males and their mother and sister were also 
asymptomatic carriers; in family C a frameshift mutation, c.1292delG, p.Ser431Ilefs*6, 
in exon 2, was detected in a 7 years old affected male and his mother. 
 
The maternal origin of mutations was confirmed in the three families studied. 
The identification of a NR0B1 mutation in a family has important implications: a correct 
clinical diagnosis can be established, appropriate clinical management of affected 
members and suitable genetic counselling can be offered, female carriers can be 
identified and disease can be prevented.  
